ABOS
Acumen Pharmaceuticals, Inc.Closed1.82−0.21 −10.15%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.84 +1.38%
Open
2.00
Prev close
2.02
Day range
1.812.00
52-week range
1.503.60
Volume
646.04K1.48×
Mkt cap
131.26M
P/E ttm
—
Fwd P/E
-1.27
EPS ttm
-1.64
Div yield
0.00%
Earnings
Aug 12, 2026
From 52w high
−49.58%
ABOS earnings and estimates
ABOS Next Report
Yahoo Finance · Nasdaq
Report date
Wed, Nov 11
Before the open
EPS consensus
$−0.38
range −0.45 – −0.24
EPS growth vs year ago
+13.9%
year ago −0.44
Revenue consensus
$0
0.0% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±2.3%
average move · beat 3 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 12, 2026 BMO | −0.45 | −0.41 | −11.02% | $0 | +1.6% | +10.9% |
| Mar '26 | May 12, 2026 BMO | −0.33 | −0.46 | +28.26% | $0 | −3.5% | −15.2% |
| Dec '25 | Mar 26, 2026 BMO | −0.41 | −0.56 | +26.29% | $0 | −3.0% | −3.0% |
| Sep '25 | Nov 12, 2025 BMO | −0.44 | −0.68 | +35.23% | $0 | −1.0% | −15.7% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.38 | −0.45−0.24 | +13.9% | $0 | 0.0% | −0.38 0.0% | −0.42 +10.5% | 1 / 1 |
| Next quarter Dec 2026 | −0.40 | −0.49−0.25 | +2.5% | $0 | 0.0% | −0.40 0.0% | −0.45 +10.5% | 1 / 0 |
| Current year Dec 2026 | −1.59 | −1.79−1.27 | +20.5% | $0 | 0.0% | −1.59 0.0% | −1.58 −0.3% | 1 / 2 |
| Next year Dec 2027 | −1.43 | −1.47−1.37 | +9.8% | $0 | 0.0% | −1.43 0.0% | −1.51 +4.9% | 2 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.43 | −0.45−0.41 | 2 | 0 / 0 |
| Dec 2026 | −0.32 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −1.60 | −1.71−1.51 | 3 | 0 / 0 |
| Dec 2027 | −1.67 | −2.17−1.37 | 3 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.